Journal of the Neurological Sciences
Volume 217, Issue 1 , Pages 55-60 , 15 January 2004

Ischemic stroke after using over the counter products containing ephedra

  • Cassandra Chen

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-317-274-4455; fax: +1-317-278-4918.
    • Department of Neurology, Indiana University School of Medicine, Clinical Building 291, 541 Clinical Drive, Indianapolis, IN 46202, USA
    • ,
  • Jose Biller

      Affiliations

    • Department of Neurology, Indiana University School of Medicine, Clinical Building 291, 541 Clinical Drive, Indianapolis, IN 46202, USA
    • ,
  • Steven J. Willing

      Affiliations

    • Section of Neuroradiology, Department of Radiology, Indiana University School of Medicine, Indianapolis, IN, USA
    • ,
  • Alfredo M. Lopez

      Affiliations

    • Department of Neurology, Indiana University School of Medicine, Clinical Building 291, 541 Clinical Drive, Indianapolis, IN 46202, USA

Received 23 May 2003 ,Revised 1 August 2003 ,Accepted 26 August 2003.

References 

  1. Charatan F. Ephedra supplement may have contributed to sportsman's death. Br. Med. J. 2003;326:464–465
  2. Kapral MK, Bondy SJ. Cervical manipulation and risk of stroke. Canadian Medical Association Journal. 2001;165:907–908
  3. Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y, et al.  Risk of arterial thrombosis in relation to oral contraceptives study: oral contraceptives and the risk of ischemic stroke. Stroke. 2002;33:1202–1208
  4. Kaberi-Otarod J, Conetta R, Kundo K, Farkash A. Ischemic stroke in a user of Thermadrene: a case study in alternative medicine. Clinical Pharmacology and Therapeutics. 2002;72:343–346
  5. Department of Health and Human Resources . HHS acts to reduce potential risks of dietary supplements containing Ephedra. FDA News. 2003;PO3-13:1–5
  6. Stein M. Are herbal products dietary supplements or drugs? An important question for public safety. Clinical Pharmacology and Therapeutics. 2002;71:411–413
  7. Fellow E. Ephedra/ephedrine: cardiovascular and CNS effects. Canadian Medical Association Journal. 2002;166:633–636
  8. News . Voluntary recall of ephedra products not enough, MD says. Canadian Medical Association. 2002;166:225–228
  9. Haller C, Benowitz N. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. New England Journal of Medicine. 2000;343:1833–1838
  10. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, et al.  Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance. JAMA. 2003;289:1537–1545
  11. Morgenstern LB, Viscoli CM, Kernan WN, Brass LM, Broderick JP, Feldmann E, et al.  Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology. 2003;132–135
  12. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. American Journal of Hospital Pharmacy. 2000;57:963–969
  13. Bruno A, Nolte KB, Chapin J. Stroke associated with ephedrine use. Neurology. 1993;43:1313–1316
  14. Fallis RJ, Fisher M. Cerebral vasculitis and hemorrhage associated with phenylpropanolamine. Neurology. 1985;35:405–407
  15. Wooten MR, Khangure MS, Murphy MJ. Intracerebral hemorrhage and vasculitis related to ephedrine abuse. Annals of Neurology. 1983;13:337–340

PII: S0022-510X(03)00262-4

doi: 10.1016/j.jns.2003.08.012

Journal of the Neurological Sciences
Volume 217, Issue 1 , Pages 55-60 , 15 January 2004

Article Tools

* Image Usage & Resolution